Apr 28, 2026 08:45AM
Apr 28, 2026 08:45AM
Feb 23, 2026 09:36AM
Feb 23, 2026 08:09AM
Feb 23, 2026 06:01AM
Feb 23, 2026 06:01AM
Feb 4, 2026 09:01AM Arcellx presents data on anito-cel binder specificity at TANDEM meeting
Feb 4, 2026 09:00AM
Jan 21, 2026 04:00PM
Jan 21, 2026 04:00PM
Dec 8, 2025 02:54AM
Dec 6, 2025 02:00PM
Nov 3, 2025 09:00AM
Aug 7, 2025 04:00PM Arcellx Provides Second Quarter 2025 Financial Results and Business Highlights
Jul 31, 2025 07:08AM
May 14, 2025 09:30AM
May 8, 2025 04:00PM
Mar 20, 2025 04:00PM
Mar 20, 2025 04:00PM
Feb 27, 2025 04:00PM
Jan 2, 2025 04:00PM Biotech outlook for 2025: Stifel
Dec 8, 2024 11:00PM
Nov 7, 2024 04:00PM
Nov 6, 2024 07:23AM
Nov 5, 2024 09:01AM
Nov 5, 2024 09:00AM
Aug 8, 2024 04:00PM
May 9, 2024 04:08PM Kite (GILD) and Arcellx (ACLX) Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
May 9, 2024 04:05PM
May 9, 2024 04:05PM
May 9, 2024 04:00PM
May 7, 2024 04:00PM
Apr 4, 2024 04:00PM
Mar 20, 2024 04:00PM
Mar 18, 2024 11:59AM Arcellx Inc. (ACLX) PT Raised to $81 at Needham
Feb 29, 2024 04:00PM
Feb 28, 2024 04:00PM
Dec 8, 2023 04:02PM
Dec 8, 2023 04:00PM
Nov 15, 2023 06:00AM
Nov 15, 2023 06:00AM
Nov 15, 2023 06:00AM Kite and Arcellx Announce Expansion in Strategic Partnership
Nov 13, 2023 04:00PM
Nov 2, 2023 09:00AM
Oct 26, 2023 04:00PM
Aug 14, 2023 04:00PM
Aug 14, 2023 04:00PM
Jun 20, 2023 06:53AM
Jun 20, 2023 06:09AM Arcellx (ACLX) Announces Clinical Hold for its iMMagine-1 Phase 2 Clinical Program
Jun 19, 2023 07:46PM

322,240 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All